News tagged with tysabri

FDA investigating PML in patient taking MS drug

(HealthDay)—The U.S. Food and Drug Administration is investigating the possible association between a rare brain infection and the multiple sclerosis (MS) drug Gilenya (fingolimod), according to a drug ...

Aug 31, 2013
popularity 4.5 / 5 (2) | comments 0

Royalty Pharma lets Elan takeover bid expire

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

Jun 18, 2013
popularity not rated yet | comments 0

Judge halts Royalty Pharma's bid for Elan stock

Irish drugmaker Elan Corp.'s fight against a takeover bid by Royalty Pharma has spilled into U.S. federal court, where a judge has issued a temporary restraining order preventing Royalty from completing its offer to buy the ...

Jun 04, 2013
popularity not rated yet | comments 0

Elan moves to deter takeover bid

(AP)—Irish drug maker Elan Corp. announced Monday it will pay shareholders a recurring special dividend linked to the sales of the multiple sclerosis treatment Tysabri.

Mar 04, 2013
popularity not rated yet | comments 0

FDA clears safety test to screen Tysabri patients

(AP) -- The Food and Drug Administration on Friday approved a new diagnostic test to help identify patients who have an increased risk of developing a rare brain infection while taking Biogen Idec's multiple sclerosis drug ...

Jan 20, 2012
popularity 5 / 5 (2) | comments 0